Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice

25 Nov 2020

Abstract excerpt

gene editing for chronic HBV infections, and it suggests that with further optimization, this approach may offer a plausible way to treat or even cure chronic HBV infections.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Viral gastroenteritis research and epidemiology
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33473359
DOI: 10.1016/j.omtm.2020.11.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized micePMID 33473359Read ↗

CRISPR/Cas9 for hepatitis B virus infection treatmentSemantic proximity Read ↗

Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus.Semantic proximity Read ↗

Gene-Editing and RNA Interference in Treating Hepatitis B: A ReviewSemantic proximity Read ↗

CRISPR/Cas and Hepatitis B Therapy: Technological Advances and Practical BarriersSemantic proximity Read ↗

Tackling hepatitis B Virus with CRISPR/Cas9: advances, challenges, and delivery strategiesSemantic proximity Read ↗

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virusSemantic proximity Read ↗

Recent Progress and Future Prospective in HBV Cure by CRISPR/CasSemantic proximity Read ↗

Development of an in vivo delivery system for CRISPR/Cas9-mediated targeting of hepatitis B virus cccDNASemantic proximity Read ↗

Application of CRISPR/Cas9 Technology to HBVSemantic proximity Read ↗

CRISPR-Cas9 Targeting of Hepatitis B Virus Covalently Closed Circular DNA Generates Transcriptionally Active Episomal VariantsSemantic proximity Read ↗

A CRISPR-Cas9 platform for primary human hepatocytes enables arrayed screening and in vivo validation of HBV host factorsSemantic proximity Read ↗

Multiplex Gene Editing Suppresses Random Integration of Hepatitis B Virus DNA in Chronically Infected LiverSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.